ATHN 2: Factor Switching Study

CompletedOBSERVATIONAL
Enrollment

310

Participants

Timeline

Start Date

September 30, 2015

Primary Completion Date

June 30, 2020

Study Completion Date

June 30, 2020

Conditions
Hemophilia
Interventions
BIOLOGICAL

Factor VIII Replacement Products for Hemophilia which were FDA approved after January 1, 2013

Prophylaxis for prevention of bleeding, various regimens.

BIOLOGICAL

Factor IX Replacement Products for Hemophilia which were FDA approved after January 1, 2013

Prophylaxis for prevention of bleeding, various regimens.

Trial Locations (27)

10065

Weill Cornell Medicine, New York

14621

Mary M. Gooley Hemophilia Center, Rochester

15213

The Hemophilia Center of Western Pennsylvania, Pittsburgh

19104

Children's Hospital of Philadelphia (CHOP), Philadelphia

Pennsylvania Comprehensive Hemophilia and Thrombophilia Program / Hospital of the University of Pennsylvania, Philadelphia

20010

Children's National Medical Center, Washington D.C.

21205

Johns Hopkins University Medical Center, Baltimore

30322

Children's Healthcare of Atlanta/Emory, Atlanta

33607

St. Joseph's Children's Hospital, Tampa

33701

Johns Hopkins All Children's Hospital, St. Petersburg

38105

St Jude Children's Research Hospital, Memphis

46260

Indiana Hemophilia and Thrombosis Center (IHTC), Indianapolis

48109

University of Michigan Hemophilia and Coagulation Disorders Program, Ann Arbor

48823

Michigan State University Center for Bleeding and Clotting Disorders, East Lansing

53201

Blood Center of Wisconsin, Milwaukee

61615

Bleeding and Clotting Disorders Institute, Peoria

64108

Children's Mercy Hospital, Kansas City

70112

Louisiana Center for Bleeding and Clotting Disorders, New Orleans

75235

UTSW Medical Center at Dallas/Children's Medical Center, Dallas

80045

University of Colorado Denver Hemophilia and Thrombosis Center, Aurora

92122

University of California San Diego (UCSD), San Diego

97239

Oregon Health and Science University, Portland

98104

Washington Center for Bleeding Disorders Bloodworks Northwest d/b/a Puget Sound Blood Center, Seattle

06520

Yale Hemophilia Treatment Center, New Haven

04074

Maine Hemophilia and Thrombosis Center, Scarborough

02115

Boston Hemophilia Center at Children's Hospital of Boston, Boston

03756

Dartmouth-Hitchcock Comprehensive Hemophilia and Thrombosis Center, Lebanon

All Listed Sponsors
collaborator

Shire

INDUSTRY

collaborator

CSL Behring

INDUSTRY

collaborator

Bioverativ Therapeutics Inc.

INDUSTRY

collaborator

Bayer

INDUSTRY

lead

American Thrombosis and Hemostasis Network

NETWORK